Evogene Ltd. (EVGN) reporting calendar
Evogene Ltd. files periodic reports with the SEC as EVGN on Nasdaq. Atlas tracks 13 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 26 Mar 2026
- Reports on record
- 13
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 26 Mar 2026 | 85 days | 0001178913-26-001767 |
| 20-F | 31 Dec 2024 | 27 Mar 2025 | 86 days | 0001178913-25-001092 |
| 20-F | 31 Dec 2023 | 28 Mar 2024 | 88 days | 0001178913-24-001137 |
| 20-F | 31 Dec 2022 | 30 Mar 2023 | 89 days | 0001178913-23-001224 |
| 20-F | 31 Dec 2021 | 31 Mar 2022 | 90 days | 0001178913-22-001337 |
| 20-F | 31 Dec 2020 | 2 Apr 2021 | 92 days | 0001178913-21-001263 |
| 20-F | 31 Dec 2019 | 27 Apr 2020 | 118 days | 0001178913-20-001229 |
| 20-F | 31 Dec 2018 | 29 Apr 2019 | 119 days | 0001178913-19-001243 |
| 20-F | 31 Dec 2017 | 30 Mar 2018 | 89 days | 0001178913-18-001042 |
| 20-F | 31 Dec 2016 | 28 Apr 2017 | 118 days | 0001178913-17-001247 |
| 20-F | 31 Dec 2015 | 25 Apr 2016 | 116 days | 0001178913-16-005166 |
| 20-F | 31 Dec 2014 | 30 Apr 2015 | 120 days | 0001178913-15-001382 |
| 20-F | 31 Dec 2013 | 8 Apr 2014 | 98 days | 0001178913-14-001220 |
Source: SEC EDGAR company submissions for CIK 0001574565. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.